BMT CTN Protocol 0202

Autologous vs. Non-Myeloablative Allogeneic Hematopoietic Stem Cell  Transplantation (HSCT) for Patients with Chemosensitive Follicular Non-Hodgkin’s  Lymphoma Beyond First Complete Response or First Partial Response

Below are  protocol-related doucments, which may be periodically updated.

This protocol closed to patient accrual on March 2, 2006.